Family Caregivers of Patients With a High-Grade Glioma
Annemarie Coolbrandt(KU Leuven), Bernadette Dierckx de Casterlé(KU Leuven), Sonja Borgenon(KU Leuven), Marleen Decruyenaere(KU Leuven), Steven De Vleeschouwer(KU Leuven), Paul M. Clément(Universitair Ziekenhuis Leuven), Anne Mees(KU Leuven), Wendy Sterckx(KU Leuven)
Cited by 37
Related Papers
Lomustine and Bevacizumab in Progressive Glioblastoma
|New England Journal of Medicine|2017|994
Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034
|Journal of Clinical Oncology|2009|573
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
|The Lancet Oncology|2016|504